StockData

Establishment Labs vs Sanara MedTech

ESTA and SMTI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ESTA and SMTI compare

Establishment Labs is the larger company, worth 6.9 times as much as Sanara MedTech ($2.1B against $301M).

Establishment Labs grew revenue faster over the last twelve months (38.3% versus 13.0% for Sanara MedTech).

Establishment Labs keeps more of each dollar of sales as profit, with a net margin of −14.6% compared with −29.2% at Sanara MedTech.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricESTASMTI
Size and price
Market cap$2.1B$301M
Share price$69.51$32.73
Change, 1 year8.6%51.9%
Change, 5 years4.7%14.2%
Beta (5Y)0.671.43
Employees1,004108
StockData Score
Total score66
Valuation score00
Growth score33
Performance score2 (better)1
Health score12 (better)
Dividend score00
Valuation
P/S7.8×2.7× (better)
P/B133×37.9× (better)
EV/EBITDA–30.4×
P/FCF–66.8×
FCF yield−1.0%1.5% (better)
Fair value–$13.42
Margin of safety–−144%
Growth
Revenue growth (TTM)38.3% (better)13.0%
Revenue growth, 5Y average20.0%45.9% (better)
Profitability
Gross margin70.2%93.0% (better)
Operating margin−6.6%7.7% (better)
Net margin−14.6% (better)−29.2%
FCF margin−8.2%4.1% (better)
Return on equity−241%−148% (better)
Return on invested capital−6.7%13.1% (better)
Financial health
Debt / equity17.175.85 (better)
Net debt / EBITDA–2.85
Interest coverage−0.6×1.2× (better)
Current ratio3.57 (better)2.58
Altman Z-score2.743.76 (better)
Piotroski F-score33
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions95.8%19.4%
Held by insiders9.6%14.9%
Insider net buying, 12 months−$35.5M–
Short interest, % of float14.6%5.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.